Is it possible to change the psychopathic traits of substance abusers treated in faith-based therapeutic communities – does the length  of treatment matter?

Vojislava V. Bugarski Ignjatovic; Vanja V. Vajagić; Željka D. Nikolašević

doi:10.2298/VSP160914169B

Vojislava V. Bugarski Ignjatovic Faculty of Medicine, Department of Psychology, University of Novi Sad, Serbia
Vanja V. Vajagić University of Novi Sad, Faculty of Medicine, Department of Special rehabilitation and education, Novi Sad, Serbia
Željka D. Nikolašević Faculty of Medicine, Department of Psychology, University of Novi Sad, Serbia

DOI: https://doi.org/10.2298/VSP160914169B

Keywords: substance-related disorders, faith healing, therapeutic community, psychopathology, antisocial personality disorder, surveys and questionnaires

Abstract

Abstract

Background/Aim. Faith-based therapeutic communities (FBTCs) have been increasingly employed as a modality in the treatment of substance abuse. Their program influences behavioral, psychological, cognitive and social changes among their beneficiaries. The aim of the study was to evaluate whether the duration of treatment in a FBTC may contribute to changes in the traits that make the four Hare’s psychopathy dimensions – Antisocial behavior, Lifestyle, Interpersonal relationships, and Psychopathic affect. Another aim was to assess whether abusers on treatment in a FBTC have more pronounced psychopathic traits compared with subjects with no history of substance abuse. Methods. The study included 59 male subjects, of an average age of 29 years, and of different educational levels, who were divided into three groups: substance abusers who had spent one year in the FBTC; substance abusers who had successfully completed a two-year program in the FBTC; and healthy controls with no history of substance abuse. The Psychopathy Assessment Questionnaire (PAQ) was employed to assess the four Hare’s dimensions of psychopathy. Results. There were statistically significant differences among the groups on the Antisocial Behavior dimension. For this dimension, there were differences among non-abusers and both groups of substance abusers, with non-abusers achieving the lowest average scores. There were no statistically significant differences between two groups of substance abusers in any of the studied dimensions. Conclusion. The longer, two-year treatment in the FBTC did not contribute to changes of the psychopathic traits more than the one-year treatment. In addition, subjects with history of substance abuse undergoing treatment in the FBTC had more pronounced psychopathic traits compared with non-abusers.

References

REFERENCES

Johnson BR, Tompkins RB, Webb D. Objective hope: Assessing the effectiveness of faith-based organizations: A review of the literature. Philadelphia, PA: Center for Research on Religion and Urban Civil Society; 2002.

Fadzli A, Sudirman AF, Sudirman AF. Spiritual and Traditional Rehabilitation Modality of Drug Addiction in Malaysia. Int J Hum Soc Sci 2011; 1(14): 175–81.

Davis MT. Religious and non-religious components in sub-stance abuse treatment: A comparative analysis of faith-based and secular interventions. J Soc Work 2014; 14(3): 243–59.

Neff JA, Shorkey CT, Windsor LC. Contrasting faith-based and traditional substance abuse treatment programs. J Subst Abuse Treat 2006; 30(1): 49–61.

Hester RD. Spirituality and faith-based organizations: Their role in substance abuse treatment. Adm Policy Ment Health 2002; 30(2): 173–8.

John E. Fetzer Institute. Multidimensional measurement of re-ligiousness/spirituality for use in health research: A report of the Fetzer Institute/National Institute on Aging Working Group. Kalamazoo, MI: Fetzer Institute; 2003.

Powell LH, Shahabi L, Thoresen CE. Religion and spirituality. Linkages to physical health. Am Psychol 2003; 58(1): 36–52.

Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Looking back on cocaine dependence: Reasons for recovery. Am J Addict 2003; 12(5): 398–411.

Mason SJ, Deane FP, Kelly PJ, Crowe TP. Do spirituality and religiosity help in the management of cravings in substance abuse treatment. Subst Use Misuse 2009; 44(13): 1926–40.

Gorsuch RL. Religious aspects of substance abuse and re-covery. J Soc Issues 1995; 51(2): 65–83.

Miller WR. Spiritual aspects of addictions treatment and re-search. Mind Body Med 1997; 2(1): 37–43.

Vanderplasschen W, Colpaert K, Autrique M, Rapp R, Pearce S, Broekaert E, et al. Therapeutic Communities for Addictions: A Review of Their Effectiveness from a Recovery-Oriented Perspective. Sci World J 2013; 2013: 427817.

Vanderplasschen W, Vandevelde S, Broekaert E. Therapeutic communities for treating addictions in Europe. Luxembourg: Publications Office of the European Union; 2014.

De Leon G. Community as method. Therapeutic communities for special populations and special settings. Vestport, Konek-tikat: Greenwood Publishing Group; 1997.

Broekaert E. Therapeutic communities for drug users: Descrip-tion and overview. In: Rawlings B, Yates R, editors. Therapeutic communities for the treatment of drug users. London: Jessica Kingsley Publishers; 2001. p. 29–42.

De Leon G. The therapeutic community: Theory, model and method. New York: Springer Publishing Company; 2000.

Hare RD, Neumann CS. Psychopathy as a clinical and empirical construct. Annu Rev Clin Psychol 2008; 4: 217–46.

Jainhill NG, DeLeon G, Pinkham L. Psychiatric diagnoses among substance abusers in the therapeutic community. J Psy-choactive Drugs 1986; 18(3): 209–13.

Sacks JG, Levy NM. Objective personality changes in residents of a therapeutic community. Am J Psychiatry 1979; 136(6): 796–9.

Samuel DB, LaPaglia DM, Maccarelli LM, Moore BA, Ball SA. Personality disorders and retention in a therapeutic community for substance dependence. Am J Addict 2011; 20(6): 555–62.

Ansell EB, Grilo CM. Personality disorders. In: Hersen M, Turner SM, Beidel DC, editors. Adult Psychopathology and Diagnosis. Hoboken, NJ: Wiley; 2007. p. 633–78.

Hare RD. Psychopathy a clinical construct whose time has come. Crim Justice Behav 1996; 23(1): 25–54.

Hobson J, Shine J, Roberts R. How do psychopaths behave in a prison therapeutic community? Psychol Crime Law 2000; 6(2): 139–54.

Richards HJ, Casey JO, Lucente SW. Psychopathy and treatment response in incarcerated female substance abusers. Crim Jus-tice Behav 2003; 30(2): 251–76.

Hare RD. Psychopathy: theory and research. Oxford, England: John Wiley; 1970.

Novović Z, Smederevac S, Biro M. Evaluation of psychopathic deviation (PAQ - questionnaire). In: Biro M, Smederevac S, Novović Z, editors. Evaluation of psychological and psychopa-thological phenomena. Belgrade: Center for marriage and family; 2009. p. 73–88.(Serbian)

Rueve ME, Welton RS. Violence and mental illness. Psychiatry (Edgmont) 2008; 5(5): 34–48.

Cleckley H. The mask of sanity. St. Louis, IL: Mosby; 1976.

Hare RD. Without conscious: The Disturbing World of the Psychopaths Among Us. New York: Pocket books; 1993.

Ogloff JR, Wong S, Greenwood A. Treating criminal psychopaths in a therapeutic community program. Behav Sci Law 1990; 8(2): 181–90.

Hart SD, Hare RD. Psychopathy and antisocial personality dis-order. Curr Opin Psychiatry 1996; 9(2): 129–32.

Harris GT, Rice ME. Treatment of psychopathy: A review of empirical findings. In: Patrick CJ, editor. Handbook of psycho-pathy. New York: Guilford Press; 2006. p. 555–72.

Weisz J, Kazdin A. Evidence-based psychotherapies for child-ren and adolescents. New York: Guilford Press; 2010.

Salekin RT. Psychopathy and therapeutic pessimism. Clinical lore or clinical reality? Clin Psychol Rev 2002; 22(1): 79–112.

Salekin RT, Worley C, Grimes RD. Treatment of psychopathy: a review and brief introduction to the mental model approach for psychopathy. Behav Sci Law 2010; 28(2): 235–66.